UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K -- CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 18, 1995
INTERNATIONAL RESEARCH AND DEVELOPMENT CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware 0-7059 38-1688261
(State or other Commission File (I.R.S. Employer
jurisdiction of Number Identification No.)
incorporation or
organization)
500 North Main Street, Mattawan Michigan 49071
(Address of principal executive offices) (Zip Code)
(616) 668-3336
Registrant's telephone number, including area code
Not Applicable
(Former name, former address and former fiscal year,
if changed since last report.)
Item 5. Other Events.
On May 18, 1995, the registrant issued a press release, a copy of which is
attached as Exhibit 99.5 to this Form 8-K and incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
Exhibit Number Description
99.5 Press release dated May 18, 1995
issued by the Registrant
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
INTERNATIONAL RESEARCH AND
DEVELOPMENT CORPORATION
(Registrant)
Date: May 19, 1995
/s/ Curt Dally
_____________________________
Curt Dally
Secretary and Treasurer
PRESS RELEASE
For Release on May 18, 1995
For More Information, Call:
Mr. Michael Feder
Chief Executive Officer
International Research and Development Corporation (IRDC) announced today that
Michael Feder, currently serving as Acting President of the Corporation, has
been elected to the additional position of Chief Executive Officer. Mr. Feder
is President of Stratford Partners, Inc., a firm specializing in business
recoveries.
Dr. H.P.K. Agersborg, a Director of the Corporation, has been named Chairman of
the Board. Dr. Agersborg currently serves as a consultant to the pharmaceutical
industry and previously was President of Wyeth-Ayerst Research Division of
American Home Products Corporation.
Francis X. Wazeter, Ph.D., previously Chairman of the Board and Chief Executive
Officer of the Corporation, will remain a Director of the Corporation.
The primary business of International Research and Development Corporation is
the safety evaluation of pharmaceutical and veterinary drugs, agricultural
products, and chemicals. Studies are performed on behalf of various
manufacturers of such products, both foreign and domestic, and on behalf of
governmental agencies.
The common stock of International Research and Development Corporation is traded
in the over-the-counter national market. The NASDAQ symbol for the common stock
is IRDV.
